Identification of Grb2‐associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of Grb2‐associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma

Published:2022-07-13 Issue:10 Volume:36 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem & Molecular Tox

Author:

Wang Ning¹^ORCID,Zhou Xue²^ORCID,Wang Xue³,Zhu Xiaowei¹

Affiliation:

1. The Third Central Hospital of Tianjin Tianjin China

2. Department of Nephrology, Tianjin Haihe Hospital Haihe Clinical College of Tianjin Medical University Tianjin China

3. Department of Respiratory Medicine The Third Central Hospital of Tianjin Tianjin China

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.23166

Reference37 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance

4. Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis

5. Cancer Statistics, 2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy;Inflammation Research;2024-06-19

2. CXXC finger protein 1 (CFP1) bridges the reshaping of genomic H3K4me3 signature to the advancement of lung adenocarcinoma;Signal Transduction and Targeted Therapy;2023-09-21

3. Comprehensive analysis identifies ARHGEF6 as a potential prognostic and immunological biomarker in lung adenocarcinoma;Computers in Biology and Medicine;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3